Life Sciences
Europe Guide 2024 : Germany
Band 1
Contact number
+49 69 71 99 01Chambers Review
Clifford Chance has a standout life sciences team boasting an impressive roster of leading pharmaceutical and medical technology companies among its client base. It is noted for its strong capability in large cross-border transactions as well as the handling of regulatory advisory and litigation mandates regarding reimbursement, advertising, market access and distribution. The team offers additional expertise in healthtech and the digitalisation sectors. It also acts for legislative bodies, trade associations and start-ups in the sector and is able to draw on expertise in data protection, IT and IP law to assist with projects involving the commercial exploitation of healthcare data.
Work Highlights
- Clifford Chance advised Merck on matters of data protection, cyber security and compliance in the pharmaceutical sector.
Strengths
Provided by Chambers
"Besides in-depth knowledge about the regulatory framework and profound knowledge of the market environment, Clifford Chance provides a highly developed international network which allows precise and highly responsive legal advice, especially in cross-border matters."
"Besides in-depth knowledge about the regulatory framework and profound knowledge of the market environment, Clifford Chance provides a highly developed international network which allows precise and highly responsive legal advice, especially in cross-border matters."
Notable Practitioners
Peter Dieners is a highly regarded practitioner who often acts for pharmaceutical and medical technology companies and associations as well as PE investors on a range of regulatory issues, including market access, insurance reimbursement and policy changes. He also represents his clients in connected disputes.
Ulrich Reese is highly respected in the market for his extensive knowledge of life sciences regulations, including classification of medical products, misleading advertising and unfair competition as well as changes to regulations. His impressive client base includes high-profile multinational pharmaceuticals corporations, government task forces and pharmaceuticals associations.